Where Vaccine Hopes Run High
Bloomberg Businessweek|September 21, 2020
Indonesia is the site of one of the leading trials. It’s eager to take the risks
By Harry Suhartono and Lyu Dong

On a scorching August day in Bandung, the capital of West Java province, two dozen volunteers arrive at a small community clinic inside a narrow alley to take part in the last stage of one of the world’s fastest-moving trials for a coronavirus vaccine.

There, surrounded by cramped homes and kids playing outdoors without masks, they prepare to take an experimental shot developed by China’s Sinovac Biotech Ltd., which many in Indonesia hope will bring an end to the destruction wreaked by the virus. With about a quarter- million infections, Indonesia’s outbreak is the second-worst in Southeast Asia after the Philippines, its daily case count hitting records every week since the end of August.

“I’m tired of seeing how we are dealing with this disease. I just want to help in any way that I can,” says 27-year-old microbiologist Abinubli Tariswafi Mawarid, one of the volunteers. “I believe the vaccine is the magic bullet to solve this pandemic. This is the most appropriate solution.”

Few countries have embraced the possibility of a vaccine more fervently than Indonesia, where the government projects the pandemic will push an additional 4.9 million people into poverty, weighing heavily on its population of about 270 million. The country offers a look at the outsize expectations driving the speedy development of Covid-19 inoculations globally—as well as the potential pitfalls—as entire nations look for a quick fix.

In Bandung, a resort area of more than 2 million, the clinical trials, run by state-owned pharmaceutical company PT Bio Farma, have been accompanied by much fanfare. Many of the 1,620 people from Bandung and nearby towns who’ve enrolled in the Sinovac trial have been interviewed on local media. The region’s police chief received a shot (which could have been the trial vaccine or a placebo), as did its governor, who promoted the experience on Instagram. Bio Farma has been working with regulators for expedited approval of the Sinovac vaccine. It says it will manufacture from 10 million to 20 million doses even before it gets a green light so the shot will be immediately available.

Iin Susanti, head of planning and business strategy for Bio Farma, says broader distribution will begin only after Indonesian regulators give emergency approval. President Joko Widodo has said his government is aiming for such authorization for CoronaVac, as the shot is called, by January. The first batches will go to health workers.

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BLOOMBERG BUSINESSWEEKView All

Young U.S. Jews Shift on Israel

Millennial and Gen Z progressives question American support of Israeli policies, a point of tension for the Democratic Party

4 mins read
Bloomberg Businessweek
June 14, 2021

Fever Pitch

A British tonic maker aims to conquer the U.S. with its premium mixers

4 mins read
Bloomberg Businessweek
June 14, 2021

Welcome to the Trump Coast

The former president’s strategic retreat to Mar-a-Lago has helped turn Florida into a new home base for Republicans

10+ mins read
Bloomberg Businessweek
June 14, 2021

THE SEDITION HUNTERS

Amateur sleuths pore over photos and videos online to ID Capitol rioters

6 mins read
Bloomberg Businessweek
June 14, 2021

The FOMO Economy

From AMC to Dogecoin to houses, buying seems driven as much by anxiety as by hope

7 mins read
Bloomberg Businessweek
June 14, 2021

KING OF CARDS

Sports trading cards are having a moment. And no one promotes the industry like Ken Goldin

10+ mins read
Bloomberg Businessweek
June 14, 2021

Pay Attention to the Man Behind the Curtain

Vladimir Putin’s tolerance for criminal hackers will be on the agenda when he meets with President Biden on June 16

4 mins read
Bloomberg Businessweek
June 14, 2021

It's TEQUILA O'CLOCK In NYC

Jimmy Buffett’s Margaritaville is a hit song, a chill state of mind, a billion-dollar marketing empire, and the new best worst attraction in Times Square

10+ mins read
Bloomberg Businessweek
June 14, 2021

Is Streaming the Limit for Sky?

As its content providers start online services, the broadcaster pivots to create its own shows

5 mins read
Bloomberg Businessweek
June 14, 2021

A Pop-Up Store Hits the Road

Cuyana’s store-on-a-truck is a cost-effective way to quickly test locations and products

3 mins read
Bloomberg Businessweek
June 14, 2021
RELATED STORIES

The Last Pandemic

Technological breakthroughs and policy progress mean humanity may never again have to endure a disaster like Covid-19.

10+ mins read
Reason magazine
May 2021

Gain Of Function

How much risk of an accidental pandemic is too much?

10+ mins read
New York magazine
January 4-17, 2021

Drugmaker Backpedals on Specialty Status for COVID-19 Drug

Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment.

2 mins read
Techlife News
March 28, 2020

Can Blood from Coronavirus Survivors Treat the Newly ILL?

Hospitals are gearing up to test if a century-old treatment used to fight off flu and measles outbreaks in the days before vaccines, and tried more recently against SARS and Ebola, just might work for COVID-19, too: using blood donated from patients who’ve recovered.

4 mins read
AppleMagazine
March 27, 2020

Ask the Doctor

Introducing our new monthly feature, Ask the Doctor. Our healthcare partners will be answering your questions.

3 mins read
Volusia Parent
November 2019

Pinterest To Direct Vaccine Related Searches To Health Orgs

Pinterest said it will try to combat misinformation about vaccines by showing only information from health organizations when people search.

1 min read
Techlife News
August 31, 2019

Measels For The One Percent

Vaccines, Waldorf schools, and the problem with liberal Luddites.

10+ mins read
New York magazine
May 27 - June 9, 2019

Welcome to the Age of Robot Animals

Why build robots when you can just tweak animals?

6 mins read
New York magazine
February 8–21, 2016

निजी अस्पतालों के लिए वैक्सीन की रेट तय

इलेक्ट्रानिक वाउचर के जरिये कोई भी व्यक्ति टीकाकरण में गरीबों की कर सकता है मदद

1 min read
Samagya
June 09, 2021

Vaccine Passports: State Of Play

As vaccinations are rolled out worldwide, discussions continue about the possibility of having some kind of digital document to prove that travellers are protected against Covid-19.

1 min read
Business Traveller UK
May - June 2021